jueves, 23 de enero de 2020

Patient groups often aren’t transparent about industry funding

Morning Rounds
Shraddha Chakradhar

Patient groups often aren’t transparent about industry funding

Patient groups often aren’t transparent about their funding from the drug and health care industries, according to a new analysis of studies that analyzed such connections. Depending on the patient groups that were evaluated, data from 26 studies revealed that anywhere between 20% to almost 90% of these organizations received some sort of industry funding. A smaller subset of studies included in the review found that only a quarter of patient groups — which are often focused on advocacy and education — disclosed the funding on their websites. Of the studies that looked at the average amount of funding per patient group, the range varied from around $200,000 to more than $356,000. Although the findings were based on a limited set of studies, the authors of the review suggest greater transparency about industry ties among patient groups.

No hay comentarios: